-
-
-
-
-
-
-
Goldman sees a buying opportunity in this EU biopharma stock
-
-
-
-
-
-
-
argenx SE (ARGX) PT Raised to $1,060 at Oppenheimer
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on argenx SE (ARGX)
-
-
-
-
-
-
-
Jefferies Reiterates Buy Rating on argenx SE (ARGX)
-
-
-
-
-
-
-
Wolfe Research Downgrades argenx SE (ARGX) to Peerperform
-
-
-
-
-
-
-
Truist Securities: 'Is Biotech Back?!'
-
-
-
-
-
-
-
Deutsche Bank Downgrades argenx SE (ARGX:BB) (ARGX) to Hold
-
416,801 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

